Healthcare -
Biotechnology - NASDAQ - US
$ 1.055
-4.09 %
$ 55.6 M
Market Cap
-0.36
P/E
ALXO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ALXO - ALX Oncology Holdings Inc.
59.3 M
LAST VALUE
389.75%
2 YEAR CAGR
800.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR